HIGHLY ELEVATED CA125 AND TUBOOVARIAN ABSCESS MIMICKING OVARIAN-CARCINOMA

被引：8
|
作者：
MACRI, CI
VASILEV, SA
机构：
[1] CITY HOPE NATL MED CTR,DEPT GYNECOL ONCOL,DUARTE,CA 91010
[2] USN,BETHESDA NAVAL HOSP,MED CTR,DEPT OBSTET & GYNAECOL,BETHESDA,MD 20814
来源：
GYNECOLOGIC AND OBSTETRIC INVESTIGATION | 1994年 / 37卷 / 02期
关键词：
CA125; TUBOOVARIAN ABSCESS; SALPINGITIS; OVARIAN MASS;
D O I：
10.1159/000292544
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Elevated serum CA125 levels may be caused by any condition which produces peritoneal irritation as well as by the presence of various malignancies. This report of a case with atypical presentation of tubo-ovarian abscess and CA125 level of 1,160 U/ml serves to re-emphasize cautious operative planning in patients desirous of reproductive capability in the face of findings highly consistent with probable malignancy. This is the highest reported serum CA125 level in a reproductive age woman with well-documented reversible benign disease.
引用
收藏
页码：143 / 144
页数：2
相关论文
共 50 条
  • [21] USE OF CA-125 TO PREDICT SURVIVAL OF PATIENTS WITH OVARIAN-CARCINOMA
    RUSTIN, GJS
    GENNINGS, JN
    NELSTROP, AE
    COVARRUBIAS, H
    LAMBERT, HE
    BAGSHAWE, KD
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) : 1667 - 1671
  • [22] IMMUNOCYTOCHEMICAL AND SEROLOGICAL DETECTION OF CEA AND CA-125 IN OVARIAN-CARCINOMA
    WEIKEL, W
    WELLENS, E
    BRUMM, C
    MOBUS, V
    BECK, T
    MITZE, M
    TUMORDIAGNOSTIK & THERAPIE, 1994, 15 (04) : 134 - 142
  • [23] ROLE OF CA-125 AS TUMOR-MARKER IN OVARIAN-CARCINOMA
    KREBS, HB
    GOPLERUD, DR
    KILPATRICK, SJ
    MYERS, MB
    HUNT, A
    OBSTETRICS AND GYNECOLOGY, 1986, 67 (04): : 473 - 477
  • [24] USE OF THE CA-125 ANTIGEN IN DIAGNOSIS AND MONITORING OF OVARIAN-CARCINOMA
    BAST, RC
    KNAPP, RC
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1985, 19 (06): : 354 - 356
  • [25] EVALUATION OF CA-125 AS TUMOR-MARKER IN OVARIAN-CARCINOMA
    SCHRUURS, B
    VANKRIEKEN, L
    DECKERS, C
    LONGUEVILLE, J
    DEHERTOGH, R
    THOMAS, K
    TUMOUR BIOLOGY, 1985, 6 (04): : 417 - 417
  • [26] Elevated serum CA125 predicts recurrence in patients with completely resected ovarian clear cell carcinoma
    Ebata, T.
    Yunokawa, M.
    Bun, S.
    Noguchi, E.
    Shimomura, A.
    Shimoi, T.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Kato, T.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [27] ELEVATION OF SERUM CA 125 PRIOR TO DIAGNOSIS OF AN EPITHELIAL OVARIAN-CARCINOMA
    BAST, RC
    SIEGAL, FP
    RUNOWICZ, C
    KLUG, TL
    ZURAWSKI, VR
    SCHONHOLZ, D
    COHEN, CJ
    KNAPP, RC
    GYNECOLOGIC ONCOLOGY, 1985, 22 (01) : 115 - 120
  • [28] RELATIONSHIP BETWEEN CA 125 AND PROGESTERONE PRODUCTION IN WOMEN WITH OVARIAN-CARCINOMA
    MAHLCK, CG
    GRANKVIST, K
    KJELLGREN, O
    BACKSTROM, T
    CANCER, 1990, 65 (09) : 2058 - 2063
  • [29] LEVELS AND CLINICAL-APPLICATIONS OF A MONOCLONAL ANTIBODY-DEFINED ANTIGEN (CA125) IN PATIENTS WITH EPITHELIAL OVARIAN-CARCINOMA
    TORRE, GC
    REMBADO, R
    BARBETTI, V
    LUCCHESE, V
    VALLE, C
    VIGLIERCIO, GP
    VALLE, PF
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1985, 29 (1-2): : 159 - 160
  • [30] HORMONAL-REGULATION OF CA125 TUMOR-MARKER EXPRESSION IN HUMAN OVARIAN-CARCINOMA CELLS - INHIBITION BY GLUCOCORTICOIDS
    KARLAN, BY
    AMIN, W
    CASPER, SE
    LITTLEFIELD, BA
    CANCER RESEARCH, 1988, 48 (12) : 3502 - 3506
12345